Feng Ren

Feng Ren serves as co-CEO, CSO, Head of Drug R&D at Insilico Medicine, Inc. Insilico Medicine, Inc operates in the research sector with approximately 280.0 employees. The company is headquartered in Shanghai, Shanghai. Insilico Medicine, Inc generates annual revenue of 30000000.0. To date, Insilico Medicine, Inc has raised 2156000000.0 in total funding, with the most recent round being Series E.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Insilico Medicine, Inc.
• • 282 executive contacts are available in Shanghai.
• • Our database includes 201,465 c suite-level executives.

Route 53 Amazon SES Gmail Google Apps Microsoft Office 365 Amazon AWS Outlook YouTube Dropbox Mobile Friendly Google Analytics Google Tag Manager Remote AI

artificial intelligence deep learning reinforcement learning drug discovery aging research longevity biomarker development generative adversarial networks gans gansrl biotechnology pharmaceuticals bioinformatics information technology life sciences biotechnology research generative artificial intelligence target identification automated drug design clinical trial prediction multi-omics analysis computer-aided drug design ai-driven biotechnology molecular synthesis novel drug candidates fibrosis treatment cancer therapy ai algorithms preclinical candidate ai drug design disease modeling target discovery platform pharmaceutical ai synthetic lethality virtual drug design ai in oncology clinical trials biotechnology partnerships ai in medicine real-world evidence drug repurposing ai healthcare biopharmaceutical innovations computational biology drug development ai platforms therapeutic targets drug efficacy molecular engineering pharma pipeline biomedical research ai-powered solutions personalized medicine regulatory approval pharmaceutical collaborations innovative therapies ai in pharmacology biotech investments research & development biotech industry advancements ai-based analytics healthcare innovation generative ai pharma.ai aging therapeutics fibrosis cancer immunology cns disorders innovative drugs ai-driven solutions molecular design automated laboratory partnerships pharmaceutical industry research collaborations machine learning clinical-stage biotechnology robotic lab integration venture capital sustainable chemistry healthspan non-hormonal contraceptives precision medicine drug pipeline customer-centric solutions global reach industry recognition information technology & services medical health care health wellness & fitness hospital & health care

MC

Michelle Chen Chief Business Officer at Insilico Medicine, Inc

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Feng Ren in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Insilico Medicine, Inc.

Feng Ren's Position in the MessageCEO Database

• •Feng Ren is 1 of 2 verified executive contacts we track at Insilico Medicine, Inc.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •280 verified executive contacts in Shanghai are in the database.
• •17 verified contacts work at research companies in the 280.0 employee range (same size as Insilico Medicine, Inc).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Feng Ren directly?

Feng Ren's verified email address is available to MessageCEO Pro subscribers. They currently serve as co-CEO, CSO, Head of Drug R&D at Insilico Medicine, Inc. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Feng Ren work for?

Feng Ren is co-CEO, CSO, Head of Drug R&D at Insilico Medicine, Inc, a company in the research sector with 280.0 employees. The company is based in Shanghai, Shanghai.

Can I pitch or sell to Feng Ren?

As co-CEO, CSO, Head of Drug R&D at Insilico Medicine, Inc, Feng Ren is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Feng Ren directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Feng Ren in?

Feng Ren works in the research industry as co-CEO, CSO, Head of Drug R&D at Insilico Medicine, Inc. MessageCEO provides verified contact information for executives across all major industries.

Is Feng Ren's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Feng Ren's profile is kept up-to-date with the latest available information.

Last updated: October 27, 2026